Ellevest Inc’s OptimizeRx OPRX Stock Holding History

Ellevest Inc’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-125	Closed	-$2.1K	–	2020
2022 Q4	$2.1K	Buy	+125	New	+$2.16K	﹤0.01%	1378
2022 Q2	–	Sell	-8	Closed	–	–	1601
2022 Q1	$0	Sell	8 -4	-33%	-$177	﹤0.01%	1574
2021 Q4	$1K	Hold	12	–	–	﹤0.01%	1311
2021 Q3	$1K	Sell	12 -7	-37%	-$439	﹤0.01%	1296
2021 Q2	$1K	Buy	+19	New	+$967	﹤0.01%	1179

Other funds holding OPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ellevest Inc's OPRX Position: Q1 2023 in Review

Ellevest Inc sold out of OptimizeRx (OPRX) in Q1 2023, closing a stake of 125 shares — an estimated $2.1K sold.

Ellevest Inc first reported a position in OPRX in Q2 2021 and held it in 5 quarters. The position peaked at $2.1K in Q4 2022. 110 funds tracked by Wall St. Rank hold OPRX as of Q1 2023.

Ellevest Inc reported no remaining OptimizeRx position as of Q1 2023 after selling out during the quarter.
Ellevest Inc sold 125 OptimizeRx shares in Q1 2023, an estimated $2.1K.
Ellevest Inc first reported a position in OptimizeRx in Q2 2021 and held it in 5 quarters.
Ellevest Inc's OptimizeRx position peaked at $2.1K in Q4 2022.
110 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.